Targeting host-cell proteins offers a new antimicrobial strategy to inhibit microbial growth.
May expand options against resistant infections; leaves open safe target validation across pathogens.
Through understanding the intricacies of host-pathogen interactions, it is now possible to inhibit the growth of microbes, especially viruses, by targeting host-cell proteins and functions. This new antimicrobial strategy has proved effective in the laboratory and in the clinic, and it has great potential for the future.
No takes yet. Share an insight, caveat, or question.
Paul Kellam (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: